• 2025
  Chauvel C, Casalegno JS, Visseaux B, Vieillefond V, Haim-Boukozba S, Enouf V, Chanard E, Fabre M, Rameix-Welti MA, Oblette A, Giannoli JM, Paireau J, Josset L, Lina B, Gaymard A, Cauchemez S, Morfin F, Nunes MC, Bal A, Community and Hospital-Based Laboratory Surveillance for Influenza, Respiratory Syncytial Virus, and SARS-CoV-2 During the 2023-2024 Season, Lyon, France., J Med Virol 2025 Sep; 97(9): e70549.
• 2025
  Blanquart F, Vieillefond V, Visseaux B, Abou Chakra CN, Nunes MC, Jacques A, Haim-Boukobza S, Josset L, Wehrle V, Deleglise G, Duret T, Rameix-Welti MA, Lina B, Enouf V, , Bal A, Influenza vaccine effectiveness against detected infection in the community, France, October 2024 to February 2025., Euro Surveill 2025 Feb; 30(7): .
• 2025
  Traore A, Charniga K, Grellet S, Terpant G, Da Cruz H, Lamy A, Thomas N, Gbaguidi G, Mercier A, Prudhomme J, Visseaux B, Vieillefond V, Haim-Boukobza S, Giannoli JM, , , Castro-Alvarez J, Kouamen AC, Rameix-Welti MA, Beirrera-Ibraim S, Destras G, Josset L, Cauchemez S, Lina B, Coignard B, Schaeffer J, Enouf V, Bal A, Monitoring SARS-CoV-2 variants with complementary surveillance systems: risk evaluation of the Omicron JN.1 variant in France, August 2023 to January 2024., Euro Surveill 2025 Jan; 30(1): .
• 2024
  Antoine Brault, Isabelle Pontais, Vincent Enouf, Christine Debeuret, Emma Bloch, Juliette Paireau, Marie Anne Rameix-Welti, Michael White, Gaëlle Baudemont, Bruno Lina, Isabelle Parent Du Châtelet, Jean-Sébastien Casalegno, Sophie Vaux, Simon Cauchemez, Effect of nirsevimab on hospitalisations for respiratory syncytial virus bronchiolitis in France, 2023–24: a modelling study, The Lancet Child & Adolescent Health, 2024, 8 (10), pp.721-729. ⟨10.1016/S2352-4642(24)00143-3⟩.
• 2024
  Inizan C, Courtot A, Sturmach C, Griffon AF, Biron A, Bruel T, Enouf V, Demaneuf T, Munier S, Schwartz O, Gourinat AC, Médevielle G, Jouan M, van der Werf S, Madec Y, Albert-Dunais V, Dupont-Rouzeyrol M, Levels and functionality of Pacific Islanders’ hybrid humoral immune response to BNT162b2 vaccination and delta/omicron infection: A cohort study in New Caledonia., PLoS Med 2024 Sep; 21(9): e1004397.
• 2024
  Simon B Gressens, Vincent Enouf, Antoine Créon, Giovanna Melica, Francois Lemonnier, Jehan Dupuis, Taoufik El Gnaoui, Mohammad Hammoud, Karim Belhadj, Corinne Haioun, Anne Le Bouter, Sebastien Gallien, Fabien Le Bras, Slim Fourati, Serological responses against seasonal influenza viruses in patients with multiple myeloma treated or untreated with daratumumab after two doses of tetravalent vaccine, International Journal of Infectious Diseases, 2024, 146, pp.107108. ⟨10.1016/j.ijid.2024.107108⟩.
• 2024
  Charlotte Laniece Delaunay, Clara Mazagatos, Iván Martínez-Baz, Gergő Túri, Luise Goerlitz, Lisa Domegan, Adam Meijer, Ana Paula Rodrigues, Noémie Sève, Maja Ilić, Neus Latorre-Margalef, Mihaela Lazar, Marine Maurel, Aryse Melo, Blanca Andreu Ivorra, Itziar Casado, Judit Krisztina Horváth, Silke Buda, Charlene Bennett, Marit de Lange, Raquel Guiomar, Vincent Enouf, Ivan Mlinarić, Tove Samuelsson Hagey, Sorin Dinu, Mercedes Rumayor, Jesús Castilla, Beatrix Oroszi, Ralf Dürrwald, Joan O’donnell, Mariëtte Hooiveld, Verónica Gomez, Alessandra Falchi, Sanja Kurečić Filipović, Lena Dillner, Rodica Popescu, Sabrina Bacci, Marlena Kaczmarek, Esther Kissling, COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans, JAMA Network Open, 2024, 7 (7), pp.e2419258. ⟨10.1001/jamanetworkopen.2024.19258⟩.
• 2024
  Laniece Delaunay C, Mazagatos C, Martínez-Baz I, Túri G, Goerlitz L, Domegan L, Meijer A, Rodrigues AP, Sève N, Ilic M, Latorre-Margalef N, Lazar M, Maurel M, Melo A, Andreu Ivorra B, Casado I, Horváth JK, Buda S, Bennett C, de Lange M, Guiomar R, Enouf V, Mlinaric I, Samuelsson Hagey T, Dinu S, Rumayor M, Castilla J, Oroszi B, Dürrwald R, O'Donnell J, Hooiveld M, Gomez V, Falchi A, Kurecic Filipovic S, Dillner L, Popescu R, Bacci S, Kaczmarek M, Kissling E, COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans., JAMA Netw Open 2024 Jul; 7(7): e2419258.
• 2024
  Gressens SB, Enouf V, Créon A, Melica G, Lemonnier F, Dupuis J, El Gnaoui T, Hammoud M, Belhadj K, Haioun C, Le Bouter A, Gallien S, Bras FL, Fourati S, Serological responses against seasonal influenza viruses in patients with multiple myeloma treated or untreated with daratumumab after two doses of tetravalent vaccine., Int J Infect Dis 2024 May; 146(): 107108.
• 2024
  Charlotte Lanièce Delaunay, Iván Martínez-Baz, Noémie Sève, Lisa Domegan, Clara Mazagatos, Silke Buda, Adam Meijer, Irina Kislaya, Catalina Pascu, Annasara Carnahan, Beatrix Oroszi, Maja Ilić, Marine Maurel, Aryse Melo, Virginia Sandonis Martín, Camino Trobajo-Sanmartín, Vincent Enouf, Adele Mckenna, Gloria Pérez-Gimeno, Luise Goerlitz, Marit de Lange, Ana Paula Rodrigues, Mihaela Lazar, Neus Latorre-Margalef, Gergő Túri, Jesús Castilla, Alessandra Falchi, Charlene Bennett, Virtudes Gallardo, Ralf Dürrwald, Dirk Eggink, Raquel Guiomar, Rodica Popescu, Maximilian Riess, Judit Krisztina Horváth, Itziar Casado, Mª del Carmen García, Mariëtte Hooiveld, Ausenda Machado, Sabrina Bacci, Marlena Kaczmarek, Esther Kissling, COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022, Eurosurveillance, 2024, 29 (13), pp.2300403. ⟨10.2807/1560-7917.es.2024.29.13.2300403⟩.
• 2024
  Lanièce Delaunay C, Martínez-Baz I, Sève N, Domegan L, Mazagatos C, Buda S, Meijer A, Kislaya I, Pascu C, Carnahan A, Oroszi B, Ilić M, Maurel M, Melo A, Sandonis Martín V, Trobajo-Sanmartín C, Enouf V, McKenna A, Pérez-Gimeno G, Goerlitz L, de Lange M, Rodrigues AP, Lazar M, Latorre-Margalef N, Túri G, Castilla J, Falchi A, Bennett C, Gallardo V, Dürrwald R, Eggink D, Guiomar R, Popescu R, Riess M, Horváth JK, Casado I, García MDC, Hooiveld M, Machado A, Bacci S, Kaczmarek M, Kissling E, COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022., Euro Surveill 2024 Mar; 29(13): .
• 2024
  Marine Maurel, Jennifer Howard, Esther Kissling, Francisco Pozo, Gloria Pérez-Gimeno, Silke Buda, Noémie Sève, Adele Mckenna, Adam Meijer, Ana Paula Rodrigues, Iván Martínez-Baz, Ivan Mlinarić, Neus Latorre-Margalef, Gergő Túri, Mihaela Lazăr, Clara Mazagatos, Aitziber Echeverria, Stephen Abela, Marc Bourgeois, Ausenda Machado, Ralf Dürrwald, Goranka Petrović, Beatrix Oroszi, Ligita Jancoriene, Alexandru Marin, Petr Husa, Roisin Duffy, Frederika Dijkstra, Virtudes Gallardo García, Luise Goerlitz, Vincent Enouf, Charlene Bennett, Mariëtte Hooiveld, Raquel Guiomar, Camino Trobajo-Sanmartín, Vesna Višekruna Vučina, Tove Samuelsson Hagey, Ana Sofía Lameiras Azevedo, Jesús Castilla, Gerd Xuereb, Bénédicte Delaere, Verónica Gómez, Kristin Tolksdorf, Sabrina Bacci, Nathalie Nicolay, Marlena Kaczmarek, Angela Mc Rose, Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024, Eurosurveillance, 2024, 29 (8), ⟨10.2807/1560-7917.es.2024.29.8.2400089⟩.
• 2024
  Maurel M, Howard J, Kissling E, Pozo F, Pérez-Gimeno G, Buda S, Sève N, McKenna A, Meijer A, Rodrigues AP, Martínez-Baz I, Mlinarić I, Latorre-Margalef N, Túri G, Lazăr M, Mazagatos C, Echeverria A, Abela S, Bourgeois M, Machado A, Dürrwald R, Petrović G, Oroszi B, Jancoriene L, Marin A, Husa P, Duffy R, Dijkstra F, Gallardo García V, Goerlitz L, Enouf V, Bennett C, Hooiveld M, Guiomar R, Trobajo-Sanmartín C, Višekruna Vučina V, Samuelsson Hagey T, Lameiras Azevedo AS, Castilla J, Xuereb G, Delaere B, Gómez V, Tolksdorf K, Bacci S, Nicolay N, Kaczmarek M, Rose AM, Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024., Euro Surveill 2024 Feb; 29(8): .
• 2024
  Marine Maurel, Francisco Pozo, Gloria Pérez‐gimeno, Silke Buda, Noémie Sève, Beatrix Oroszi, Mariette Hooiveld, Verónica Gomez, Lisa Domegan, Iván Martínez‐baz, Maja Ilić, Anna Sara Carnahan, Maria Elena Mihai, Ana Martínez, Luise Goerlitz, Vincent Enouf, Judit Krisztina Horváth, Frederika Dijkstra, Ana Paula Rodrigues, Charlene Bennett, Camino Trobajo‐sanmartín, Ivan Mlinarić, Neus Latorre‐margalef, Alina Ivanciuc, Aurora Lopez, Ralf Dürrwald, Alessandra Falchi, Gergő Túri, Adam Meijer, Aryse Melo, Joan O'Donnell, Jesús Castilla, Vesna Višekruna Vučina, Tove Samuelsson Hagey, Mihaela Lazar, Marlena Kaczmarek, Sabrina Bacci, Esther Kissling, Influenza vaccine effectiveness in Europe: Results from the 2022–2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study, Influenza and Other Respiratory Viruses, 2024, 18 (1), pp.e13243. ⟨10.1111/irv.13243⟩.
• 2024
  Maurel M, Pozo F, Pérez-Gimeno G, Buda S, Sève N, Oroszi B, Hooiveld M, Gomez V, Domegan L, Martínez-Baz I, Ilić M, Carnahan AS, Mihai ME, Martínez A, Goerlitz L, Enouf V, Horváth JK, Dijkstra F, Rodrigues AP, Bennett C, Trobajo-Sanmartín C, Mlinarić I, Latorre-Margalef N, Ivanciuc A, Lopez A, Dürrwald R, Falchi A, Túri G, Meijer A, Melo A, O'Donnell J, Castilla J, Vučina VV, Hagey TS, Lazar M, Kaczmarek M, Bacci S, Kissling E, Influenza vaccine effectiveness in Europe: Results from the 2022-2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study., Influenza Other Respir Viruses 2024 Jan; 18(1): e13243.
• 2024
  Planas D, Staropoli I, Planchais C, Yab E, Jeyarajah B, Rahou Y, Prot M, Guivel-Benhassine F, Lemoine F, Enouf V, Simon-Loriere E, Mouquet H, Rameix-Welti MA, Schwartz O, Escape of SARS-CoV-2 Variants KP.1.1, LB.1, and KP3.3 From Approved Monoclonal Antibodies., Pathog Immun 2024 ; 10(1): 1-11.
• 2023
  Margaux M I Meslé, Mary Sinnathamby, Piers Mook, Richard Pebody, Vincent Enouf, Seasonal and inter‐seasonal RSV activity in the European Region during the COVID‐19 pandemic from autumn 2020 to summer 2022, Influenza and Other Respiratory Viruses, 2023, 17 (11), pp.e13219. ⟨10.1111/irv.13219⟩.
• 2023
  Meslé MMI, Sinnathamby M, Mook P, , Pebody R, Lakhani A, Zambon M, Popovici O, Lazăr M, Ljubović AD, Vukmir NR, Altaş AB, Avci E, Łuniewska K, Szymański K, Gargasiene G, Muralyte S, Dziugyte A, Zahra G, Gonçalves AR, Spedaliero T, Fournier G, Alvarez-Vaca D, Petrović G, Tabain I, Prosenc K, Socan M, Protic J, Dimitrijevic D, Druc A, Apostol M, Kalasnikova KK, Nikisins S, Reiche J, Cai W, Meijer A, Teirlinck A, Larrauri A, Casas I, Enouf V, Vaux S, Lomholt FK, Trebbien R, Jirincova H, Sebestova H, Rózsa M, Molnár Z, Aspelund G, Baldvinsdottir GE, Cottrell S, Moore C, Kossyvakis A, Mellou K, Sadikova O, Tamm JK, Bossuyt N, Thomas I, Staroňová E, Kudasheva L, Pleshkov B, Ikonen N, Helve O, Dickson E, Curran T, Komissarova K, Stolyarov K, Vysotskaya V, Shmialiova N, Rakočević B, Vujošević D, Abovyan R, Sargsyan S, Zakhashvili K, Machablishvili A, Koshalko O, Demchyshyna I, Mandelboim M, Glatman-Freedman A, Gunson R, Karanwal S, Guiomar R, Rodrigues AP, Bennett C, Domegan L, Kalaveshi A, Jakupi X, Ovliyakulova G, Korsun N, Vladimirova N, Seasonal and inter-seasonal RSV activity in the European Region during the COVID-19 pandemic from autumn 2020 to summer 2022., Influenza Other Respir Viruses 2023 Nov; 17(11): e13219.
• 2023
  Marine Wasniewski, Franck Boué, Céline Richomme, Etienne Simon-Lorière, Sylvie Van Der Werf, Flora Donati, Vincent Enouf, Yannick Blanchard, Véronique Beven, Estelle Leperchois, Bryce Leterrier, Sandrine Corbet, Meriadeg Le Gouil, Elodie Monchatre-Leroy, Evelyne Picard-Meyer, Investigations into SARS-CoV-2 and other coronaviruses on mink farms in France late in the first year of the COVID-19 pandemic, PLoS ONE, 2023, 18 (8), pp.e0290444. ⟨10.1371/journal.pone.0290444⟩.
• 2023
  G N Gbaguidi, L Aubert, J Schaeffer, L Fagour, A Dubremetz, Vincent Enouf, M-H Glaudon-Louveau de la Guigneraye, F Nestour, J Rosine, G dos Santos, Emergence and evolution of the Omicron SARS-CoV-2 variant in the island of Martinique, Infectious Diseases Now, 2023, 53 (4), pp.104690. ⟨10.1016/j.idnow.2023.104690⟩.
• 2023
  Gbaguidi GN, Aubert L, Schaeffer J, Fagour L, Dubremetz A, Enouf V, Glaudon-Louveau de la Guigneraye MH, Nestour F, Rosine J, Dos Santos G, Emergence and evolution of the Omicron SARS-CoV-2 variant in the island of Martinique., Infect Dis Now 2023 Jun; 53(4): 104690.
• 2023
  Marine Wasniewski, Franck Boué, Céline Richomme, Etienne Simon-Lorière, Sylvie van der Werf, Flora Donati, Vincent Enouf, Yannick Blanchard, Véronique Beven, Estelle Leperchois, Bryce Leterrier, Sandrine Corbet, Meriadeg Le Gouil, Elodie Monchatre-Leroy, Evelyne Picard-Meyer, Investigations on SARS-CoV-2 and other coronaviruses in mink farms in France at the end of the first year of COVID-19 pandemic, 2023.
• 2023
  Wasniewski M, Boué F, Richomme C, Simon-Lorière E, Van der Werf S, Donati F, Enouf V, Blanchard Y, Beven V, Leperchois E, Leterrier B, Corbet S, Le Gouil M, Monchatre-Leroy E, Picard-Meyer E, Investigations on SARS-CoV-2 and other coronaviruses in mink farms in France at the end of the first year of COVID-19 pandemic., bioRxiv 2023 Feb; (): .
• 2023
  Wasniewski M, Boué F, Richomme C, Simon-Lorière E, der Werf SV, Donati F, Enouf V, Blanchard Y, Beven V, Leperchois E, Leterrier B, Corbet S, Le Gouil M, Monchatre-Leroy E, Picard-Meyer E, Investigations into SARS-CoV-2 and other coronaviruses on mink farms in France late in the first year of the COVID-19 pandemic., PLoS One 2023 ; 18(8): e0290444.
• 2022
  Juliana Pipoli da Fonseca,Etienne Kornobis,Elodie Turc,Vincent Enouf2,Laure Lemée, Thomas Cokelaer,Marc Monot, Capturing SARS-CoV-2 from patient samples with low viral abundance: a comparative analysis, 2022 12:19274.
• 2022
  Tamara Kaleta, Lisa Kern, Samuel Leandro Hong, Martin Hölzer, Georg Kochs, Julius Beer, Daniel Schnepf, Martin Schwemmle, Nena Bollen, Philipp Kolb, Magdalena Huber, Svenja Ulferts, Sebastian Weigang, Gytis Dudas, Alice Wittig, Lena Jaki, Abdou Padane, Adamou Lagare, Mounerou Salou, Egon Anderson Ozer, Ndodo Nnaemeka, John Kofi Odoom, Robert Rutayisire, Alia Benkahla, Chantal Akoua-Koffi, Abdoul-Salam Ouedraogo, Etienne Simon-Lorière, Vincent Enouf, Stefan Kröger, Sébastien Calvignac-Spencer, Guy Baele, Marcus Panning, Jonas Fuchs, Antibody escape and global spread of SARS-CoV-2 lineage A.27, Nature Communications, 2022, 13 (1), pp.1152. ⟨10.1038/s41467-022-28766-y⟩.
• 2022
  Fillâtre P, Dufour MJ, Behillil S, Vatan R, Reusse P, Gabellec A, Velmans N, Montagne C, Geffroy Du Coudret S, Droumaguet E, Merour V, Enouf V, Buzelé R, Valence M, Guillotel E, Gagnière B, Baidaliuk A, Zhukova A, Tourdjman M, Thibault V, Grolhier C, Pronier C, Lescure FX, Simon-Loriere E, Costagliola D, Van Der Werf S, Tattevin P, Massart N, A new SARS-CoV-2 variant with high lethality poorly detected by RT-PCR on nasopharyngeal samples: an observational study., Clin Microbiol Infect 2022 Feb; 28(2): 298.e9-298.e15.
• 2021
  Charmet T, Schaeffer L, Grant R, Galmiche S, Chény O, Von Platen C, Maurizot A, Rogoff A, Omar F, David C, Septfons A, Cauchemez S, Gaymard A, Lina B, Lefrancois LH, Enouf V, van der Werf S, Mailles A, Levy-Bruhl D, Carrat F, Fontanet A, , Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France., Lancet Reg Health Eur 2021 Sep; 8(): 100171.
• 2021
  de Laval F, Grosset-Janin A, Delon F, Allonneau A, Tong C, Letois F, Couderc A, Sanchez MA, Destanque C, Biot F, Raynaud F, Bigaillon C, Ferraris O, Simon-Loriere E, Enouf V, Andriamanantena D, de Santi VP, Javelle E, Mérens A, Lessons learned from the investigation of a COVID-19 cluster in Creil, France: effectiveness of targeting symptomatic cases and conducting contact tracing around them., BMC Infect Dis 2021 May; 21(1): 457.
• 2021
  Planas D, Bruel T, Grzelak L, Guivel-Benhassine F, Staropoli I, Porrot F, Planchais C, Buchrieser J, Rajah MM, Bishop E, Albert M, Donati F, Prot M, Behillil S, Enouf V, Maquart M, Smati-Lafarge M, Varon E, Schortgen F, Yahyaoui L, Gonzalez M, De Sèze J, Péré H, Veyer D, Sève A, Simon-Lorière E, Fafi-Kremer S, Stefic K, Mouquet H, Hocqueloux L, van der Werf S, Prazuck T, Schwartz O, Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies., Nat Med 2021 May; 27(5): 917-924.
• 2021
  Pierre Garneret,Etienne Coz, Elian Martin, Jean-Claude Manuguerra, Elodie Brient-Litzler, Vincent Enouf, Daniel Felipe González Obando, Jean-Christophe Olivo-Marin, Fabrice Monti, Sylvie van der Werf, Jessica Vanhomwegen, Patrick Tabeling, Performing point-of-care molecular testing for SARS-CoV-2 with RNA extraction and isothermal amplification, PLOS ONE, 16(1), e0243712 - January 2021.
• 2020
  Grzelak L, Temmam S, Planchais C, Demeret C, Tondeur L, Huon C, Guivel-Benhassine F, Staropoli I, Chazal M, Dufloo J, Planas D, Buchrieser J, Rajah MM, Robinot R, Porrot F, Albert M, Chen KY, Crescenzo-Chaigne B, Donati F, Anna F, Souque P, Gransagne M, Bellalou J, Nowakowski M, Backovic M, Bouadma L, Le Fevre L, Le Hingrat Q, Descamps D, Pourbaix A, Laouénan C, Ghosn J, Yazdanpanah Y, Besombes C, Jolly N, Pellerin-Fernandes S, Cheny O, Ungeheuer MN, Mellon G, Morel P, Rolland S, Rey FA, Behillil S, Enouf V, Lemaitre A, Créach MA, Petres S, Escriou N, Charneau P, Fontanet A, Hoen B, Bruel T, Eloit M, Mouquet H, Schwartz O, van der Werf S, A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations., Sci Transl Med 2020 Sep; 12(559): .
• 2020
  Pierre Garneret, Etienne Coz, Elian Martin, Jean-Claude Manuguerra, Elodie Brient-Litzler, Vincent Enouf, Daniel Felipe Gonzalez Obando, Jean-Christophe Olivo-Marin, Fabrice Monti, Sylvie Van der Werf, Jessica Vanhomwegen, Patrick Jean Tabeling, Highly performing point-of-care molecular testing for SARS-CoV-2 with RNA extraction and isothermal amplification., medRxiv 2020.08.01.20166538.
• 2020
  Gámbaro F, Behillil S, Baidaliuk A, Donati F, Albert M, Alexandru A, Vanpeene M, Bizard M, Brisebarre A, Barbet M, Derrar F, van der Werf S, Enouf V, Simon-Loriere E, , Introductions and early spread of SARS-CoV-2 in France, 24 January to 23 March 2020., Euro Surveill. 2020 07; 25(26): .
• 2015
  Munoz O, De Nardi M, van der Meulen K, van Reeth K, Koopmans M, Harris K, von Dobschuetz S, Freidl G, Meijer A, Breed AC, Hill A, Kosmider R, Banks J, Stärk KD, Wieland B, Stevens K, van der Werf S, Enouf V, Dauphin G, Dundon W, Cattoli G, Capua I, , Erratum to: Genetic Adaptation of Influenza A Viruses in Domestic Animals and Their Potential Role in Interspecies Transmission: A Literature Review, Ecohealth 2015 May;.
• 2015
  Broberg E, Snacken R, Adlhoch C, Beauté J, Galinska M, Pereyaslov D, Brown C, Penttinen P, , Start of the 2014/15 influenza season in Europe: drifted influenza A(H3N2) viruses circulate as dominant subtype, Euro Surveill. 2015;20(4).
• 2015
  Munoz O, De Nardi M, van der Meulen K, van Reeth K, Koopmans M, Harris K, von Dobschuetz S, Freidl G, Meijer A, Breed A, Hill A, Kosmider R, Banks J, Stärk KD, Wieland B, Stevens K, van der Werf S, Enouf V, Dauphin G, Dundon W, Cattoli G, Capua I, , Genetic Adaptation of Influenza A Viruses in Domestic Animals and Their Potential Role in Interspecies Transmission: A Literature Review, Ecohealth 2015 Jan;.
• 2014
  Freidl GS, Meijer A, de Bruin E, de Nardi M, Munoz O, Capua I, Breed AC, Harris K, Hill A, Kosmider R, Banks J, von Dobschuetz S, Stark K, Wieland B, Stevens K, van der Werf S, Enouf V, van der Meulen K, Van Reeth K, Dauphin G, Koopmans M, , Influenza at the animal-human interface: a review of the literature for virological evidence of human infection with swine or avian influenza viruses other than A(H5N1), Euro Surveill. 2014;19(18).
• 2013
  Cauchemez S, Fraser C, Van Kerkhove MD, Donnelly CA, Riley S, Rambaut A, Enouf V, van der Werf S, Ferguson NM, Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility, Lancet Infect Dis 2014 Jan;14(1):50-56.
• 2013
  Ploin D, Chidiac C, Carrat F, Cohen B, Javouhey E, Mayaud C, Desenclos JC, Lina B, Leport C, , Complications and factors associated with severity of influenza in hospitalized children and adults during the pandemic wave of A(H1N1)pdm2009 infections–the Fluco French cohort, J. Clin. Virol. 2013 Sep;58(1):114-9.
• 2013
  Mailles A, Blanckaert K, Chaud P, van der Werf S, Lina B, Caro V, Campese C, Guéry B, Prouvost H, Lemaire X, Paty MC, Haeghebaert S, Antoine D, Ettahar N, Noel H, Behillil S, Hendricx S, Manuguerra JC, Enouf V, La Ruche G, Semaille C, Coignard B, Lévy-Bruhl D, Weber F, Saura C, Che D, , First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013, Euro Surveill. 2013;18(24).
• 2013
  Souty C, Blanchon T, Bonmarin I, Lévy-Bruhl D, Behillil S, Enouf V, Valette M, Bouscambert M, Turbelin C, Capai L, Roussel V, Hanslik T, Falchi A, Early estimates of 2014/15 seasonal influenza vaccine effectiveness in preventing influenza-like illness in general practice using the screening method in France., Hum Vaccin Immunother 2015 ; 11(7): 1621-5.
• 2013
  Guery B, Poissy J, el Mansouf L, Séjourné C, Ettahar N, Lemaire X, Vuotto F, Goffard A, Behillil S, Enouf V, Caro V, Mailles A, Che D, Manuguerra JC, Mathieu D, Fontanet A, van der Werf S, , Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission, Lancet 2013 Jun;381(9885):2265-72.
• 2013
  Pozo F, Lina B, Andrade HR, Enouf V, Kossyvakis A, Broberg E, Daniels R, Lackenby A, Meijer A, Community Network of Reference Laboratories for Human Influenza in Europe , Guidance for clinical and public health laboratories testing for influenza virus antiviral drug susceptibility in Europe, J. Clin. Virol. 2013 May;57(1):5-12.
• 2012
  LeGoff J, Rousset D, Abou-Jaoudé G, Scemla A, Ribaud P, Mercier-Delarue S, Caro V, Enouf V, Simon F, Molina JM, van der Werf S, I223R mutation in influenza A(H1N1)pdm09 neuraminidase confers reduced susceptibility to oseltamivir and zanamivir and enhanced resistance with H275Y, PLoS ONE 2012;7(8):e37095.
• 2012
  Escuret V, Cornu C, Boutitie F, Enouf V, Mosnier A, Bouscambert-Duchamp M, Gaillard S, Duval X, Blanchon T, Leport C, Gueyffier F, Van Der Werf S, Lina B, Oseltamivir-zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infections, Antiviral Res. 2012 Nov;96(2):130-7.
• 2012
  Luytjes W, Enouf V, Schipper M, Gijzen K, Liu WM, van der Lubben M, Meijer A, van der Werf S, Soethout EC, HI responses induced by seasonal influenza vaccination are associated with clinical protection and with seroprotection against non-homologous strains, Vaccine 2012 Jul;30(35):5262-9.
• 2012
  Bone A, Guthmann JP, Assal A, Rousset D, Degeorges A, Morel P, Valette M, Enouf V, Jacquot E, Pelletier B, Le Strat Y, Pillonel J, Fonteneau L, van der Werf S, Lina B, Tiberghien P, Lévy-Bruhl D, Incidence of H1N1 2009 virus infection through the analysis of paired plasma specimens among blood donors, France, PLoS ONE 2012;7(3):e33056.
• 2012
  Blanchon T, Mentré F, Charlois-Ou C, Dornic Q, Mosnier A, Bouscambert M, Carrat F, Duval X, Enouf V, Leport C, , Factors associated with clinical and virological response in patients treated with oseltamivir or zanamivir for influenza A during the 2008-2009 winter, Clin. Microbiol. Infect. 2013 Feb;19(2):196-203.
• 2011
  Lina B, Bouscambert M, Enouf V, Rousset D, Valette M, van der Werf S, S-OtrH3N2 viruses: use of sequence data for description of the molecular characteristics of the viruses and their relatedness to previously circulating H3N2 human viruses, Euro Surveill. 2011;16(50):20039.
• 2011
  Pelletier I, Rousset D, Enouf V, , Colbere-Garapin F, van der Werf S, Naffakh N, Highly heterogeneous temperature sensitivity of 2009 pandemic influenza A(H1N1) viral isolates, northern France, Euro Surveill. 2011 Oct;16(43).
• 2011
  Amato-Gauci A, Zucs P, Snacken R, Ciancio B, Lopez V, Broberg E, Penttinen P, Nicoll A, , Surveillance trends of the 2009 influenza A(H1N1) pandemic in Europe, Euro Surveill. 2011;16(26).
• 2011
  Rosenkrands I, Vingsbo-Lundberg C, Bundgaard TJ, Lindenstrøm T, Enouf V, van der Werf S, Andersen P, Agger EM, Enhanced humoral and cell-mediated immune responses after immunization with trivalent influenza vaccine adjuvanted with cationic liposomes, Vaccine 2011 Aug;29(37):6283-91.
• 2011
  Papillard-Marechal S, Enouf V, Schnuriger A, Vabret A, Macheras E, Rameix-Welti MA, Page B, Freymuth F, van der Werf S, Garbarg-Chenon A, Chevallier B, Gaillard JL, Gault E, , Monitoring epidemic viral respiratory infections using one-step real-time triplex RT-PCR targeting influenza A and B viruses and respiratory syncytial virus., J Med Virol 2011 Apr; 83(4): 695-701.
• 2010
  Devaux I, Kreidl P, Penttinen P, Salminen M, Zucs P, Ammon A, , , Initial surveillance of 2009 influenza A(H1N1) pandemic in the European Union and European Economic Area, April-September 2009, Euro Surveill. 2010 Dec;15(49).
• 2010
  Duval X, van der Werf S, Blanchon T, Mosnier A, Bouscambert-Duchamp M, Tibi A, Enouf V, Charlois-Ou C, Vincent C, Andreoletti L, Tubach F, Lina B, Mentré F, Leport C, , Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial, PLoS Med. 2010;7(11):e1000362.
• 2009
  Buchy P, Fourment M, Mardy S, Sorn S, Holl D, Ly S, Vong S, Enouf V, Peiris JS, van der Werf S, Molecular epidemiology of clade 1 influenza A viruses (H5N1), southern Indochina peninsula, 2004-2007, Emerging Infect. Dis. 2009 Oct;15(10):1641-4.
• 2009
  Charlier C, Enouf V, Lanternier F, Grandadam M, Amazzough K, Blanche S, Lecuit M, Lortholary O, van der Werf S, , Kinetics of nasopharyngeal shedding of novel H1N1 (swine-like) influenza A virus in an immunocompetent adult under oseltamivir therapy., Clin Microbiol Infect 2009 Dec; 15(12): 1189-91.
• 2009
  , Preliminary analysis of influenza A(H1N1)v individual and aggregated case reports from EU and EFTA countries, Euro Surveill. 2009 Jun;14(23):19238.
• 2009
  Surcouf C, Fabre M, Enouf V, Cadé S, Soler C, Mac Nab C, Samson T, Foissaud V, [Glycopeptide-resistant enterococci carriage: Are actual isolation and identification techniques sufficient?], Pathol. Biol. 2011 Jun;59(3):146-50.
• 2009
  Meijer A, Lackenby A, Hungnes O, Lina B, van-der-Werf S, Schweiger B, Opp M, Paget J, van-de-Kassteele J, Hay A, Zambon M, , Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season, Emerging Infect. Dis. 2009 Apr;15(4):552-60.
• 2009
  Sivadon-Tardy V, Orlikowski D, Porcher R, Sharshar T, Durand MC, Enouf V, Rozenberg F, Caudie C, Annane D, van der Werf S, Lebon P, Raphaël JC, Gaillard JL, Gault E, Guillain-Barré syndrome and influenza virus infection, Clin. Infect. Dis. 2009 Jan;48(1):48-56.
• 2008
  Rameix-Welti MA, Enouf V, Cuvelier F, Jeannin P, van der Werf S, , Enzymatic properties of the neuraminidase of seasonal H1N1 influenza viruses provide insights for the emergence of natural resistance to oseltamivir., PLoS Pathog 2008 Jul; 4(7): e1000103.
• 2007
  Maslin J, Bigaillon C, Froussard F, Enouf V, Nicand E, Acute bilateral uveitis associated with an active human herpesvirus-6 infection, J. Infect. 2007 Apr;54(4):e237-40.
• 2006
  Caron M, Enouf V, Than SC, Dellamonica L, Buisson Y, Nicand E, Identification of genotype 1 hepatitis E virus in samples from swine in Cambodia, J. Clin. Microbiol. 2006 Sep;44(9):3440-2.
• 2006
  Enouf V, Dos Reis G, Guthmann JP, Guerin PJ, Caron M, Marechal V, Nicand E, Validation of single real-time TaqMan PCR assay for the detection and quantitation of four major genotypes of hepatitis E virus in clinical specimens, J. Med. Virol. 2006 Aug;78(8):1076-82.
• 2005
  Nicand E, Armstrong GL, Enouf V, Guthmann JP, Guerin JP, Caron M, Nizou JY, Andraghetti R, Genetic heterogeneity of hepatitis E virus in Darfur, Sudan, and neighboring Chad, J. Med. Virol. 2005 Dec;77(4):519-21.
• 2004
  Grandadam M, Tebbal S, Caron M, Siriwardana M, Larouze B, Koeck JL, Buisson Y, Enouf V, Nicand E, Evidence for hepatitis E virus quasispecies, J. Gen. Virol. 2004 Nov;85(Pt 11):3189-94.
• 2003
  Enouf V, Chwetzoff S, Trugnan G, Cohen J, Interactions of rotavirus VP4 spike protein with the endosomal protein Rab5 and the prenylated Rab acceptor PRA1, J. Virol. 2003 Jun;77(12):7041-7.
• 2002
  Sapin C, Colard O, Delmas O, Tessier C, Breton M, Enouf V, Chwetzoff S, Ouanich J, Cohen J, Wolf C, Trugnan G, Rafts promote assembly and atypical targeting of a nonenveloped virus, rotavirus, in Caco-2 cells, J. Virol. 2002 May;76(9):4591-602.
• 2001
  Enouf V, Langella P, Commissaire J, Cohen J, Corthier G, Bovine rotavirus nonstructural protein 4 produced by Lactococcus lactis is antigenic and immunogenic, Appl. Environ. Microbiol. 2001 Apr;67(4):1423-8.